Home
Drugs
Capecitabine
Clinical Trials

Clinical Trials Related to Capecitabine

Related studies linked through entity extraction aliases.

A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer

Status: TERMINATED
Phase: PHASE3

An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer

Status: COMPLETED
Phase: N/A

Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer

Status: COMPLETED
Phase: PHASE2

Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Cancer

Status: COMPLETED
Phase: PHASE3

Study of Ruxolitinib in Pancreatic Cancer Patients

Status: COMPLETED
Phase: PHASE2

An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

Status: COMPLETED
Phase: N/A

Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer

Status: COMPLETED
Phase: PHASE1

Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)

Status: COMPLETED
Phase: PHASE2

Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma

Status: COMPLETED
Phase: PHASE2

E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer

Status: TERMINATED
Phase: PHASE1/PHASE2

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

Status: WITHDRAWN
Phase: PHASE1/PHASE2

Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer

Status: UNKNOWN
Phase: PHASE2

GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors

Status: COMPLETED
Phase: PHASE1

Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer

Status: COMPLETED
Phase: PHASE1/PHASE2

A Confirmation Study of Eribulin in Combination With Capecitabine

Status: COMPLETED
Phase: PHASE1/PHASE2

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

Status: UNKNOWN
Phase: PHASE3

Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma

Status: WITHDRAWN
Phase: PHASE1/PHASE2

Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer

Status: COMPLETED
Phase: PHASE1

Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas

Status: COMPLETED
Phase: PHASE1

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

Status: COMPLETED
Phase: NA